The Complex Disease Epigenetics Group, within the University of Exeter Medical School, received awards totaling more than $250,000 to better understand the causes of dementia.
Support for a three-year PhD post provided by Kirby Laing, with additional funding by BRACE for gene regulation research, allows the Epigenetics Group to continue its cutting-edge genomic research.
According to Dr. Katie Lunnon, associate professor in Epigenetics at Exeter Medical School, the funding could result in positive news for people with Alzheimer’s disease.
“If we can identify the pathways in the brain that are specifically disrupted in Alzheimer’s disease, it may give us an insight into new ways to treat people with this form of dementia,” Lunnon said.
Learn more about the Complex Disease Epigenetics Group’s funding for research into dementia.